Fundz

Alveolus Bio receives investment from Shilpa Medicare to expand operations and R&D efforts. The deal amount was not disclosed.

PRIVATEAug 04, 2025

Round Type

Venture

BostonBiotechnologyHealth Care

Investors

Shilpa Medicare Limited

Description

Alveolus Bio, a respiratory drug development biotech company, received an investment from Shilpa Medicare Limited. The amount of the deal was not disclosed. The company will use the funds to expand operations and its R&D efforts. Alveolus Bio is developing therapies for various lung diseases.

Quick answer

Alveolus Bio raised an undisclosed amount in a funding round, dated August 4, 2025. Investors: Shilpa Medicare Limited. Alveolus Bio is based in Boston, Massachusetts, United States.

How much did Alveolus Bio raise?
Alveolus Bio raised an undisclosed amount in a funding round on August 4, 2025.
Who invested in Alveolus Bio?
Shilpa Medicare Limited is named as investors in this round.
What does Alveolus Bio do?
Alveolus Bio is a team of scientists, physicians, and innovators pioneering breakthrough FDA-approved therapeutics for lung diseases.
Where is Alveolus Bio based and how big is it?
Alveolus Bio is based in Boston, Massachusetts, United States. Fundz records about 8 employees.
Who are the decision-makers at Alveolus Bio?
Fundz holds 1 contact at Alveolus Bio. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Alveolus Bio that raised within 45 days of this round, from Fundz verified event records.

  • iVeena raised $2M (Grant) on September 18, 2025.
  • MoldCo raised $8M (Seed) on September 18, 2025.
  • Crossbow Therapeutics raised $30M on September 17, 2025.
  • Osheru raised $4.8M (Seed) on September 17, 2025.
  • ARTHEx Biotech raised $87M (Series B) on September 17, 2025.
  • Genoskin raised $8.7M (Series A) on September 16, 2025.

Who to call at Alveolus Bio, and when

A new round usually means Alveolus Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Alveolus Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Alveolus Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Alveolus Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Alveolus Bio

Location

Boston, Massachusetts, United States

About

Alveolus Bio is a team of scientists, physicians, and innovators pioneering breakthrough FDA-approved therapeutics for lung diseases. Our pipeline includes preclinical stage live biotherapeutics for Idiopathic Pulmonary Fibrosis (IPF), Chronic Obstructive Pulmonary Disease (COPD), and Non-Cystic Fibrosis Bronchiectasis (NCFBE). Inhaled delivery effectively targets the distal regions of the lungs, bypassing first-pass metabolism and enhancing efficacy while reducing adverse effects, differentiating our drugs from other treatments.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Alveolus Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Alveolus Bio's next move

See what Strategic adds

Alveolus Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.